肾脏病治疗路径、选项与决策:国际患者决策辅助工具的环境扫描
该综述系统检索英文患者决策辅助工具(PtDA),纳入17个工具,评估其支持透析与保守管理共享决策的质量。工具覆盖5个国家,保守管理常仅被提示而非作为主动选项,命名多样,但使用PtDA可改善患者治疗决策。
要点
- 保守管理应作为与透析并列的主动选项,而非仅提示。
- 现有PtDA对保守管理的命名不统一,影响患者理解。
- 使用PtDA可改善患者治疗决策,应推广以支持共享决策。
核心结论
- 现有PtDA多用于透析选项或终末选择,主动支持保守管理与透析间知情决策的工具更能满足最佳实践。
研究设计与样本
- 采用环境扫描方法的系统综述,检索英文资源,从56条筛选记录中纳入17个PtDA。
主要发现
- 资源可读性良好;6篇出版物详述开发或评估研究;使用PtDA改善患者治疗决策。
关键数值与推荐
- 采用国际患者决策辅助工具标准(IPDAS)清单等指标评估质量。
- 纳入仅限英文且被识别为PtDA的资源。
临床怎么用
- 临床可选用PtDA支持患者在透析与保守管理间共享决策。
- 应确保PtDA将保守管理作为主动选项并统一命名。
局限性
- 仅纳入英文PtDA,可能遗漏其他语言工具。
- 部分资源开发或评估研究细节有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conservative management is recognized as an acceptable treatment for people with worsening chronic kidney disease; however, patients consistently report they lack understanding about their changing disease state and feel unsupported in making shared decisions about future treatment. The purpose of this review was to critically evaluate patient decision aids (PtDAs) developed to support patient-professional shared decision-making between dialysis and conservative management treatment pathways. METHODS: We performed a systematic review of resources accessible in English using environmental scan methods. Data sources included online databases of research publications, repositories for clinical guidelines, research projects and PtDAs, international PtDA expert lists and reference lists from relevant publications. The resource selection was from 56 screened records; 17 PtDAs were included. A data extraction sheet was applied to all eligible resources, eliciting resource characteristics, decision architecture to boost/bias thinking, indicators of quality such as International Standards for Patient Decision Aids Standards checklist and engagement with health services. RESULTS: PtDAs were developed in five countries; eleven were publically available via the Internet. Treatment options described were dialysis (n = 17), conservative management (n = 9) and transplant (n = 5). Eight resources signposted conservative management as an option rather than an active choice. Ten different labels across 14 resources were used to name 'conservative management'. The readability of the resources was good. Six publications detail decision aid development and/or evaluation research. Using PtDAs improved treatment decision-making by patients. Only resources identified as PtDAs and available in English were included. CONCLUSIONS: PtDAs are used by some services to support patients choosing between dialysis options or end-of-life options. PtDAs developed to proactively support people making informed decisions between conservative management and dialysis treatments are likely to enable services to meet current best practice.
引用
- Winterbottom AE, Mooney A, Russon L, et al. Kidney disease pathways, options and decisions: an environmental scan of international patient decision aids. Nephrol Dial Transplant. 2020. PMID: 32830240. doi:10.1093/ndt/gfaa102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。